Arcutis Biotherapeutics (ARQT) Treasury Shares (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Treasury Shares of $6.1 million for Q1 2026, down 14.75% year-over-year from $7.2 million in Q1 2025, and up 2.08% quarter-over-quarter from $6.0 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Treasury Shares (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- In Q1 2026, Treasury Shares fell 14.75% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $6.1 million (down 14.75% YoY), while the FY2025 annual figure was $6.0 million, down 0.79% from the prior year.
- Treasury Shares for Q1 2026 stood at $6.1 million, up from $6.0 million in the prior quarter.
- The five-year high for Treasury Shares was $7.2 million in Q1 2025, with the low at $1.6 million in Q3 2022.
- The 5-year median for Treasury Shares is $6.1 million (2024), against an average of $4.9 million.
- The sharpest annual moves came in 2022 and 2026: Treasury Shares soared 370.33% in 2022, then slipped 14.75% in 2026.
- Arcutis Biotherapeutics' Treasury Shares stood at $1.6 million in 2022, then jumped by 85.83% to $2.9 million in 2023, then soared by 106.69% to $6.1 million in 2024, then retreated by 0.79% to $6.0 million in 2025, then climbed by 2.08% to $6.1 million in 2026.
- Business Quant data shows ARQT's Treasury Shares at $6.1 million in Q1 2026, $6.0 million in Q4 2025, and $6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | 6.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.23 Mn |
| Jun 30, 2026 | 6.23 Mn |
| Mar 31, 2026 | 6.13 Mn |
| Mar 31, 2026 | 6.13 Mn |
| Dec 31, 2025 | 6.01 Mn |
| Dec 31, 2025 | 6.01 Mn |
| Sep 30, 2025 | 6.19 Mn |
| Sep 30, 2025 | 6.19 Mn |
| Jun 30, 2025 | 6.58 Mn |
| Jun 30, 2025 | 6.58 Mn |
| Mar 31, 2025 | 7.19 Mn |
| Mar 31, 2025 | 7.19 Mn |
| Dec 31, 2024 | 6.06 Mn |
| Dec 31, 2024 | 6.06 Mn |
| Sep 30, 2024 | 6.49 Mn |
| Sep 30, 2024 | 6.49 Mn |
| Jun 30, 2024 | 6.68 Mn |
| Jun 30, 2024 | 6.68 Mn |
| Mar 31, 2024 | 6.81 Mn |
| Mar 31, 2024 | 6.81 Mn |